Cellenion

Cellenion is a biotechnology startup that specializes in single cell isolation technology for sequencing and cell line development applications. The company has developed and patented CellenONE, a breakthrough technology that enables precise single-cell isolation and dispensing. This technology addresses a long-standing challenge in the scientific community, offering high throughput and unmatched recovery in manipulating micrometric-sized and delicate cells. Additionally, Cellenion is involved in bioprinting, utilizing 3D printing technologies to create spatially-controlled cell patterns. The company aims to achieve miniaturization and automation to produce reproducible models of varying complexities. Since its establishment in 2016, Cellenion operates within the Biotechnology, Health Care, Life Sciences, and Clean Energy industries, demonstrating its potential for widespread impact and innovation. Despite the absence of specific information about the headquarter and last investment, Cellenion's pioneering technology and applications position it as an intriguing prospect for potential venture capital investment.